Evidence map›Paper›PMID 41782928›Full record

ReviewFrontiers in pharmacology2026

Disruption of estrogen signaling by developmental exposure to BPA and TBT causes long term functional deficits in zebrafish retina.

J S Jensen, L Ouellette, R Harris, P Owrang, V P Connaughton

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J S Jensen *Department of Biology, American University, Washington, DC, United States.
L Ouellette *Department of Biology, American University, Washington, DC, United States.
R HarrisDepartment of Biology, American University, Washington, DC, United States.
P OwrangDepartment of Biology, American University, Washington, DC, United States.
V P ConnaughtonDepartment of Biology, American University, Washington, DC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisphenol A (BPA) and tributyltin (TBT) are two endocrine disrupting compounds (EDC) that have opposite effects on estrogen signaling. BPA is an estrogen agonist that binds to all estrogen receptor types. TBT is an aromatase inhibitor that binds to the enzyme aromatase, preventing the synthesis of estrogen from testosterone. Both estrogen receptors and aromatase are localized to the retina and estrogen signaling is required for proper eye and retinal neurogenesis. Abnormal eye growth and retinal changes are reported immediately after developmental exposure to either EDC consistent with the role of estrogen in proper neurogenesis. In this review, we examine the impact of BPA and TBT exposure on the development and function of the visual system. We focus primarily on zebrafish but include data from other species to show trends across vertebrates. We discuss a case study designed to determine if a transient developmental exposure to BPA or TBT has persistent effects that are evident in adults and if these latent outcomes reflect the opposite impact of these compounds on estrogen signaling. Surprisingly, although some opposing outcomes were observed, most differences in adult retinal function were similar between the two compounds, with varying effects noted by concentration and exposure age. Overall, we conclude that developing zebrafish retina is sensitive to EDCs that target estrogenic pathways. However, these findings cannot be explained by estrogenic modulation alone, suggesting additional mechanisms beyond their current established roles.

Indexed as

bisphenol ADanio rerioERGestrogentributyltin

Identifiers

PMID41782928
PMCPMC12953471

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.